

Cover Story
JudiciaryNews Analysis
By Matthew Bin Han Ong
The Supreme Court last week upended one of the underpinnings of administrative law by weakening the authority of federal health agencies to rely on technical expertise as they regulate medical products, issue coverage decisions, and respond to public health crises.
In Brief


Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for July 2024
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- Oncofertility coverage mandates expand to 21 states and DC as political momentum builds
Gaps persist as patients face harrowing decisions and huge copays - Natalie Phelps, whose clinical trial was delayed due to RIFs, dies of colon cancer
- GLP-1 drugs linked to dramatically lower death rates in colon cancer patients
- Shane Jacobson talks about his to-do list for ACS
Boost research, forge closer ties with cancer centers, launch an all-out campaign for resources
















